openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Warnings sections page 1 of 1 · 1 matching rows.
warnings
WARNINGS If patient has been given ipecac syrup, DO NOT give ACTIDOSE ® WITH SORBITOL or ACTIDOSE ® -AQUA until after last vomiting episode. Do not use in persons who are not fully conscious. Do not use this product unless directed by a health professional, if turpentine, corrosives, such as alkalies (lye) and strong acids, or petroleum distillates, such as kerosene, gasoline, paint thinner, cleaning fluid or furniture polish, have been ingested. This product is not recommended for use in children weighing less than 32 kg, or during multiple dose activated charcoal therapy since excessive catharsis and significant fluid and electrolyte abnormalities may occur. Keep this and all drugs out of the reach of children. Do not use Actidose ® with Sorbitol or Actidose ® -Aqua in any person known to have a rare autosomal recessive genetic intolerance to fructose. Do not use Actidose ® with Sorbitol in patients who are dehydrated. Actidose ® with Sorbitol may cause excessive diarrhea.
ADVERSE REACTIONS Activated charcoal with sorbitol has produced severe hypernatremic dehydration when used in excessive amounts in pediatric patients. 25, 27 Aspiration of activated charcoal has been reported to produce airway obstruction and a limited number of fatalities have occurred. 28,29,30,31 Bronchiolitis obliterans resulting in death has developed several weeks after the aspiration of activated charcoal. 32 Gastrointestinal obstruction associated with the use of multiple dose activated charcoal therapy has been reported. 33 An overdose of carbamazepine was responsible for the antiperistaltic effects which led to bowel obstruction.